Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -4.43% vs 18.78% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 57.78% vs -145.53% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -194.55% vs 28.57% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Beijing Hotgen Biotech Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -4.43% vs 18.78% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -23.00% vs 37.54% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 57.78% vs -145.53% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -950.00% vs 110.17% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -194.55% vs 28.57% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -505.00% vs 236.36% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






